2. Search Result
Search Result
Pathways Recommended: Antibody-drug Conjugate/ADC Related
Results for "

conjugate proteins

" in MedChemExpress (MCE) Product Catalog:

809

Inhibitors & Agonists

3

Screening Libraries

47

Fluorescent Dyes

302

Biochemical Assay Reagents

30

Peptides

1

MCE Kits

7

Inhibitory Antibodies

6

Natural
Products

2

Isotope-Labeled Compounds

26

Click Chemistry

34

Oligonucleotides

1

GMP Molecules

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-134669
    CypK

    N-Cyclopropene-L-Lysine

    		 Amino Acid Derivatives Cancer
    CypK (N-Cyclopropene-L-Lysine), a cyclopropene derivative of lysine, is efficiently incorporated into antibodies through genetic-code expansion. CypK is a minimal bioorthogonal handle for the creation of stable therapeutic protein conjugates .
    CypK
  • HY-174995
    JQ-1-Azidopropylamine

    		Target Protein Ligand-Linker Conjugates Epigenetic Reader Domain Cancer
    JQ-1-Azidopropylamine is an Target Protein Ligand-Linker Conjugate that incorporates a ligand for BRD4 (HY-78695) and a PROTAC linker (HY-151862), which recruits E3 ligases. JQ-1-Azidopropylamine can be used for synthesis of PROTAC JY-21 (HY-174975) .
    JQ-1-Azidopropylamine
  • HY-175360
    USP7 Ligand-Linker Conjugates 1

    		Target Protein Ligand-Linker Conjugates Deubiquitinase Cancer
    USP7 Ligand-Linker Conjugates 1 is an Target Protein Ligand-Linker Conjugate that incorporates a ligand for USP7 (HY-175359) and a PROTAC linker, which recruits E3 ligases. USP7 Ligand-Linker Conjugates 1 can be used for synthesis of PROTAC USP7 Degrader-1 (HY-175358) .
    USP7 Ligand-Linker Conjugates 1
  • HY-161543
    DHT/KLH

    		Biochemical Assay Reagents Inflammation/Immunology
    DHT/KLH is a conjugate of DHT (dihydrotestosterone) and keyhole limpet hemocyanin (KLH). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt linear epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    DHT/KLH
  • HY-W011134
    Palmitic acid N-hydroxysuccinimide

    		Biochemical Assay Reagents Others
    Palmitic acid N-hydroxysuccinimide is used to conjugate proteins to prepare targeted delivery vectors. Palmitic acid N-hydroxysuccinimide can be used as lipophilic electrophile. Palmitic acid N-hydroxysuccinimide can be used for the covalent connection between palmitic acid and ovalbumin. Palmitic acid N-hydroxysuccinimide can be used to synthesize cetacyl derivatives of amino acids, aminoacyl-trNA, coenzyme A, mercaptoacetic acid and other amino and thiogenic compounds .
    Palmitic acid N-hydroxysuccinimide
  • HY-161553
    Biotin/KLH

    		Biochemical Assay Reagents Inflammation/Immunology
    Biotin/KLH is an antigen-adjuvant conjugate that consists of Biotin and Keyhole Limpet Hemocyanin (KLH). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Biotin/KLH
  • HY-161533
    Digoxin/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    Digoxin/BSA is an antigen-adjuvant conjugate of Digoxin (HY-B1049) and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Digoxin/BSA
  • HY-161560
    Tacrolimus/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    Tacrolimus/BSA is the antigen-adjuvant conjugate formed by the conjugation of Tacrolimus (HY-13756) with Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, it can enhance the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Tacrolimus/BSA
  • HY-176391
    Ad-JQ1

    		Target Protein Ligand-Linker Conjugates Epigenetic Reader Domain Cancer
    Ad-JQ1 (Compound 16) is an Target Protein Ligand-Linker Conjugate that incorporates a ligand for BRD4 (HY-78695) and a PROTAC linker (HY-176390), which recruits E3 ligases. Ad-JQ1 can be used for synthesis of PROTAC β-NF-JQ1 (HY-130256) .
    Ad-JQ1
  • HY-176364
    AZD9496-O-C3-O-C3-O-C-acid

    		Estrogen Receptor/ERR Target Protein Ligand-Linker Conjugates Cancer
    AZD9496-O-C3-O-C3-O-C-acid is a Target Protein Ligand-Linker Conjugate that incorporates a ligand for ERα (HY-12870) and a PROTAC linker, which recruits E3 ligases. AZD9496-O-C3-O-C3-O-C-acid can be used for synthesis of PROTAC AZ'6421 (HY-135312) .
    AZD9496-O-C3-O-C3-O-C-acid
  • HY-176918
    K-Ras ligand-Linker Conjugate 8

    		Target Protein Ligand-Linker Conjugates Ras Cancer
    K-Ras ligand-Linker Conjugate 8 is a Target Protein Ligand-Linker Conjugate that incorporates a ligand for KRAS (HY-162960) and a PROTAC linker, which recruits E3 ligases. K-Ras ligand-Linker Conjugate 8 can be used for synthesis of PROTAC KRAS(on) degrader ACBI-4 (HY-176792) .
    K-Ras ligand-Linker Conjugate 8
  • HY-175551
    HPK1 ligand-Linker Conjugate 1

    		Target Protein Ligand-Linker Conjugates MAP4K Cancer
    HPK1 ligand-Linker Conjugate 1 is a synthesized target protein ligand-linker conjugate that can be used for synthesis of PROTACs, such as PROTAC HPK1 Degrader-5 (HY-175547). PROTAC HPK1 Degrader-5 is a potent and orally active HPK1 PROTAC degrader with anti-tumor activity .
    HPK1 ligand-Linker Conjugate 1
  • HY-161552
    T3/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    T3/BSA is an antigen-adjuvant conjugate of T3 (thyroid hormone) and bovine serum albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    T3/BSA
  • HY-161541
    Estradiol/BSA
    1 Publications Verification

    		 Biochemical Assay Reagents Inflammation/Immunology
    Estradiol/BSA is the antigen-adjuvant conjugate formed by the coupling of Estradiol (HY-B0141) with Bovine Serum Albumin (BSA). By coupling the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Estradiol/BSA
  • HY-161526
    T3/KLH

    		Biochemical Assay Reagents Inflammation/Immunology
    T3/KLH is an antigen-adjuvant conjugate formed by the coupling of T3 (thyroid hormone) with keyhole limpet hemocyanin (KLH). By coupling the antigen with the protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    T3/KLH
  • HY-176369
    PROTAC BRD4 ligand-1-NH-PEG-phenol-PEG-COOtBu

    		Target Protein Ligand-Linker Conjugates Epigenetic Reader Domain Cancer
    PROTAC BRD4 ligand-1-NH-PEG-phenol-PEG-COOtBu is an Target Protein Ligand-Linker Conjugate that incorporates a ligand for BRD4 and a PROTAC linker. PROTAC BRD4 ligand-1-NH-PEG-phenol-PEG-COOtBu can be used for synthesis of PROTAC BRD4 Degrader-14 (HY-138637) .
    PROTAC BRD4 ligand-1-NH-PEG-phenol-PEG-COOtBu
  • HY-153424
    PROTAC SMARCA2 degrader-1

    		Target Protein Ligand-Linker Conjugates Cancer
    PROTAC SMARCA2 degrader-1 (compound ex7) is a BRM2 (SMARCA2) degrader (DC50<0.1 μM). PROTAC SMARCA2 degrader-1 is also an E3 ubiquitin ligase binding linker useful in research of cancers. PROTAC SMARCA2 degrader-1 is a target protein ligand-linker conjugate .
    PROTAC SMARCA2 degrader-1
  • HY-151792
    Pomalidomid-C6-PEG3-butyl-N3

    		E3 Ligase Ligand-Linker Conjugates Metabolic Disease Inflammation/Immunology Cancer
    Pomalidomid-C6-PEG3-butyl-N3 is a click chemistry reagent containing an azide group. Pomalidomid-C6-PEG3-butyl-N3 also is a crosslinker-E3 ligase ligand conjugate, which be used in click reactive protein degrader building block for PROTAC research. Pomalidomid-C6-PEG3-butyl-N3 also can be used in the template for synthesis of targeted protein degrader . It contains an azide group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing alkyne groups. It can also undergo ring strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
    Pomalidomid-C6-PEG3-butyl-N3
  • HY-147050
    Ahx-DM1

    		Target Protein Ligand-Linker Conjugates Others
    Ahx-DM1 (compound 2A) is a conjugate of protein/peptide which can be combined with a therapeutic, diagnostic or labelling agent .
    Ahx-DM1
  • HY-175374
    RIPK1 ligand-Linker Conjugate-1

    		Target Protein Ligand-Linker Conjugates RIP kinase Cancer
    RIPK1 ligand-Linker Conjugate-1 is a Target Protein Ligand-Linker Conjugate that incorporates a ligand for RIPK1 (HY-175371) and a PROTAC linker (HY-175373), which recruits E3 ligases. RIPK1 ligand-Linker Conjugate-1 can be used for synthesis of PROTAC RIPK1 Degrader-1 (HY-175370) .
    RIPK1 ligand-Linker Conjugate-1
  • HY-176788
    EGFR Ligand-Linker Conjugates 1

    		Target Protein Ligand-Linker Conjugates EGFR Cancer
    EGFR Ligand-Linker Conjugates 1 is an Target Protein Ligand-Linker Conjugate that incorporates a ligand for EGFR (HY-150905) and a PROTAC linker, which recruits E3 ligases. EGFR Ligand-Linker Conjugates 1 can be used for synthesis of PROTAC EGFR degrader 3 (HY-144605) .
    EGFR Ligand-Linker Conjugates 1
  • HY-178046
    OSBP ligand-Linker Conjugate 1

    		Oxysterol-binding Protein-related Protein (ORP) Target Protein Ligand-Linker Conjugates Cancer
    OSBP ligand-Linker Conjugate 1 is a Target Protein Ligand-Linker Conjugate that incorporates a ligand for OSBP (HY-178035) and a PROTAC linker, which recruits E3 ligases. OSBP ligand-Linker Conjugate 1 can be used for synthesis of PROTAC OSBP Degrader-1 (HY-178034) .
    OSBP ligand-Linker Conjugate 1
  • HY-175333
    c-Met ligand-Linker Conjugate 1

    		Target Protein Ligand-Linker Conjugates c-Met/HGFR Cancer
    c-Met ligand-Linker Conjugate 1 is an Target Protein Ligand-Linker Conjugate that incorporates a ligand for c-Met (HY-W425461) and a PROTAC linker (HY-151862), which recruits E3 ligases. c-Met ligand-Linker Conjugate 1 can be used for synthesis of PROTAC c-Met degrader-5 (HY-175320) .
    c-Met ligand-Linker Conjugate 1
  • HY-157338
    NHS-Ala-Ala-Asn-active metabolite

    		ADC Linker Kinesin Cancer
    NHS-Ala-Ala-Asn-active metabolite is a cleavable antibody-drug conjugate (ADC) linker for synthesis of kinesin spindle protein (KSP)inhibitor .
    NHS-Ala-Ala-Asn-active metabolite
  • HY-176791
    CDK12-Cyclin K Ligand-Linker Conjugates 1

    		Target Protein Ligand-Linker Conjugates CDK Cancer
    CDK12-Cyclin K Ligand-Linker Conjugates 1 is an Target Protein Ligand-Linker Conjugate that incorporates a ligand for CDK12-Cyclin K (HY-176790) and a PROTAC linker (HY-W244922), which recruits E3 ligases. CDK12-Cyclin K Ligand-Linker Conjugates 1 can be used for synthesis of PROTAC PP-C8 (HY-144691) .
    CDK12-Cyclin K Ligand-Linker Conjugates 1
  • HY-158279
    Gentamicin/OVA

    		Antibiotic Bacterial Inflammation/Immunology
    Gentamicin/OVA is an antigen-adjuvant conjugate conjugate of Gentamicin (HY-A0276A) and ovalbumin (OVA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and can enhance cross-presentation and the production of antigen-specific T cells.
    Gentamicin/OVA
  • HY-161566
    DHT/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    DHT/BSA is an antigen-adjuvant conjugate formed by the coupling of DHT (dihydrotestosterone) and bovine serum albumin (BSA). By conjugating the antigen with the protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    DHT/BSA
  • HY-176363
    Adavosertib-C3-NH-Boc

    		Target Protein Ligand-Linker Conjugates Wee1 Cancer
    Adavosertib-C3-NH-Boc is a Target Protein Ligand-Linker Conjugate that incorporates a ligand for Wee1 (HY-10993) and a PROTAC linker (HY-W011561), which recruits E3 ligases. Adavosertib-C3-NH-Boc can be used for synthesis of PROTAC Pomalidomide-C3-adavosertib (HY-133618) .
    Adavosertib-C3-NH-Boc
  • HY-175193
    N-Deshydroxyethyl Dasatinib-C3-NH2

    N-Deshydroxyethyl BMS-354825-C3-NH2

    		 Target Protein Ligand-Linker Conjugates Src Cancer
    N-Deshydroxyethyl Dasatinib-C3-NH2 is an Target Protein Ligand-Linker Conjugate that incorporates a ligand for LCK (HY-107447) and a PROTAC linker (HY-76667), which recruits E3 ligases. N-Deshydroxyethyl Dasatinib-C3-NH2 can be used for synthesis of PROTAC SJ11646 (HY-175281) .
    N-Deshydroxyethyl Dasatinib-C3-NH2
  • HY-176872
    SMARCA2 Ligand-Linker Conjugate-4

    		Target Protein Ligand-Linker Conjugates SWI/SNF Complex Cancer
    SMARCA2 Ligand-Linker Conjugate-4 is a Target Protein Ligand-Linker Conjugate that incorporates a ligand for SMARCA2 (HY-178414) and a PROTAC linker, which recruits E3 ligases. SMARCA2 Ligand-Linker Conjugate-4 can be used for synthesis of PROTAC SMARCA2 degrader-35 (HY-176871) .
    SMARCA2 Ligand-Linker Conjugate-4
  • HY-147050A
    Ahx-DM1 TFA

    		Target Protein Ligand-Linker Conjugates Others
    Ahx-DM1 (TFA) (compound 2A) is a conjugate of protein/peptide which can be combined with a therapeutic, diagnostic or labelling agent .
    Ahx-DM1 TFA
  • HY-161528
    T3/OVA

    		Biochemical Assay Reagents Inflammation/Immunology
    T3/OVA is an antigen-adjuvant conjugate formed by conjugating T3 (thyroxine) with ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    T3/OVA
  • HY-161544
    Cholyglycine/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    Cholyglycine/BSA is a conjugate of Cholyglycine and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the production of antigen-specific T cells.
    Cholyglycine/BSA
  • HY-161587
    Chloramphenicol/OVA

    		Biochemical Assay Reagents Inflammation/Immunology
    Chloramphenicol/OVA is a conjugate of Chloramphenicol (HY-B0239) and Ovalbumin (OVA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes and can enhance cross-presentation and the production of antigen-specific T cells.
    Chloramphenicol/OVA
  • HY-161583
    Marijuana/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    Marijuana/BSA is the antigen-adjuvant conjugate of Marijuana and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or destroy major epitopes, and it can enhance cross-presentation and the production of antigen-specific T cells.
    Marijuana/BSA
  • HY-161581
    Metronidazole/OVA

    		Biochemical Assay Reagents Inflammation/Immunology
    Metronidazole/OVA is a conjugate of Metronidazole (HY-B0318) and Ovalbumin (OVA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Metronidazole/OVA
  • HY-161549
    Phosphotyrosine/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    Phosphotyrosine/BSA is an antigen-adjuvant conjugate formed by coupling Phosphotyrosine with Bovine Serum Albumin (BSA). By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Phosphotyrosine/BSA
  • HY-161548
    Metronidazole/KLH

    		Biochemical Assay Reagents Inflammation/Immunology
    Metronidazole/KLH is a conjugate of Metronidazole (HY-B0318) and Keyhole Limpet Hemocyanin (KLH). By conjugating the antigen with the protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes and can enhance cross-presentation and the generation of antigen-specific T cells.
    Metronidazole/KLH
  • HY-161529
    Angiotensin I/BSA

    		Angiotensin Receptor Inflammation/Immunology
    Angiotensin I/BSA is an antigen-adjuvant conjugate of Angiotensin I and bovine serum albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Angiotensin I/BSA
  • HY-161531
    Diethylstilbestrol/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    Diethylstilbestrol/BSA is a conjugate of Diethylstilbestrol (HY-14598) and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the production of antigen-specific T cells.
    Diethylstilbestrol/BSA
  • HY-163556
    COT/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    COT/BSA is the antigen-adjuvant conjugate of COT (cyclooctatetraene) and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes and can enhance cross-presentation and the generation of antigen-specific T cells.
    COT/BSA
  • HY-161542
    Isoniazid/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    Isoniazid/BSA is an antigen-adjuvant conjugate of Isoniazid (HY-B0329) and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Isoniazid/BSA
  • HY-161555
    Clenbuterol/KLH

    		Biochemical Assay Reagents Inflammation/Immunology
    Clenbuterol/KLH is an antigen-adjuvant conjugate of Clenbuterol (HY-B1615) and Keyhole Limpet Hemocyanin (KLH). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Clenbuterol/KLH
  • HY-161554
    Clenbuterol/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    Clenbuterol/BSA is an antigen-adjuvant conjugate of Clenbuterol (HY-B1615) and Bovine Serum Albumin (BSA). By conjugating the antigen with a protein adjuvant, it can enhance the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Clenbuterol/BSA
  • HY-161532
    Eugenol/OVA

    		Biochemical Assay Reagents Inflammation/Immunology
    Eugenol/OVA is an antigen-adjuvant conjugate formed by the conjugation of Eugenol (HY-N0337) with Ovalbumin (OVA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt key epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Eugenol/OVA
  • HY-161591
    SEM/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    SEM/BSA is an antigen-adjuvant conjugate formed by the conjugation of SEM (furanesalin) with bovine serum albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    SEM/BSA
  • HY-161540
    Oxytetracycline/OVA

    		Biochemical Assay Reagents Inflammation/Immunology
    Oxytetracycline/OVA is an antigen-adjuvant conjugate formed by the coupling of Oxytetracycline (HY-B0275) with ovalbumin (OVA). By conjugating the antigen with a protein adjuvant, it enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or destroy the major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Oxytetracycline/OVA
  • HY-163555
    BZO/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    BZO/BSA is an antigen-adjuvant conjugate formed by the coupling of BZO (benzodiazepine) with bovine serum albumin (BSA). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the production of antigen-specific T cells.
    BZO/BSA
  • HY-161594
    Furazolidone/BSA

    		Biochemical Assay Reagents Inflammation/Immunology
    Furazolidone/BSA is the antigen-adjuvant conjugate of Furazolidone (HY-B1336) and bovine serum albumin (BSA). By conjugating the antigen with the protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the major epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
    Furazolidone/BSA
  • HY-161558
    Ractopamine/KLH

    		Biochemical Assay Reagents Inflammation/Immunology
    Ractopamine/KLH is an antigen-adjuvant conjugate of Ractopamine (HY-113781) and Keyhole Limpet Hemocyanin (KLH). By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt major epitopes, and it can enhance cross-presentation and the production of antigen-specific T cells.
    Ractopamine/KLH

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: